ABLG - ETF AI Analysis
Top Page
Abacus FCF International Leaders ETF (ABLG)
ABLG’s rating suggests it is a solid but not top-tier international equity ETF, with its quality supported by leading positions in TSMC and ASML, whose strong financial performance and strategic focus on advanced technologies and AI provide important growth drivers. Additional strength comes from holdings like Novartis and Tencent, which add diversified growth from healthcare and technology. The main risk is the fund’s heavy tilt toward a relatively small group of tech-oriented names, some of which face valuation concerns, bearish technical trends, or operational challenges that can add volatility.
ABLG vs. SPDR S&P 500 ETF (SPY)
- AUM
- 13.06M
- Region
- Global Ex-U.S.
- Expense Ratio
- 0.54%
- Beta
- 0.81
- Issuer
- Abacus
- Inception Date
- Jun 27, 2017
- Dividend Yield
- 2.93%
- Asset Class
- Equity
- Index Tracked
- No Underlying Index
ABLG Summary
The Abacus Fcf International Leaders ETF (ABLG) invests in leading companies around the world that generate strong free cash flow, a sign they have money left over after expenses to reinvest or return to shareholders. It does not track a specific index, but follows a theme of owning cash‑rich global leaders across many sectors, with a big tilt to technology and industrials. Well-known holdings include TSMC and ASML. Someone might invest in ABLG for international diversification and long-term growth potential. A key risk is that its stock prices can go up and down with global markets, especially tech-related shares.
How much will it cost me?
This ETF has an expense ratio of 0.54%, which means you’ll pay about $5.40 per year for every $1,000 you invest. That’s higher than the average ETF because it’s actively managed and focuses on a specialized strategy of selecting international companies with strong free cash flow.
What would affect this ETF?
This ETF focuses on cash‑generating market leaders outside the U.S., with heavy exposure to technology and industrial companies like TSMC, ASML, SK hynix, Rolls‑Royce, and Trane, so it could benefit from global growth in semiconductors, digital services, and infrastructure spending. However, it may be hurt by rising interest rates, economic slowdowns in key regions, regulatory pressures on big tech and healthcare names such as Tencent, Novartis, and Roche, or geopolitical tensions that disrupt international trade and supply chains.
ABLG Top 10 Holdings
ABLG is leaning heavily into the global chip boom, with TSMC and ASML doing much of the heavy lifting as their rising shares ride the AI and semiconductor wave. Advantest and SK hynix add even more semiconductor flavor, though SK hynix has been more mixed lately and occasionally tugs at performance. Outside chips, shipping player Frontline has been a surprising bright spot, while Rolls-Royce and Tencent have been more of a drag. With a clear tilt toward non-U.S. tech and industrial leaders, this fund is very much a global ex-U.S. growth story.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
 TSM | TSMC | 5.58% | $729.33K | $1.88T | 33.94% | 81Outperform |
 ASML | ASML Holding | 5.36% | $700.44K | $602.71B | 45.60% | 81Outperform |
 ATEYY | Advantest | 4.89% | $639.16K | $154.05B | 55.78% | 59Neutral |
 KR:000660 | SK hynix Inc. | 4.75% | $619.99K | KRW 1033.53T | 149.65% | ―― |
 NVS | Novartis | 3.61% | $471.38K | $296.91B | 31.14% | 80Outperform |
 RHHBY | Roche Holding | 3.16% | $413.18K | $390.13B | 50.87% | 74Outperform |
 FRO | Frontline | 2.98% | $388.78K | $12.67B | 133.48% | 70Neutral |
 RYCEY | Rolls-Royce | 2.94% | $383.93K | $137.21B | 8.11% | 63Neutral |
 SUBCY | Subsea 7 | 2.83% | $369.78K | $10.43B | 90.93% | 74Outperform |
 HK:0700 | Tencent Holdings | 2.62% | $342.42K | HKD 3.46T | -41.08% | 75Outperform |
ABLG Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For ABLG, the sentiment is Negative. The current price of 28.31 is below the 20-day moving average (MA) of 29.61, below the 50-day MA of 30.48, and below the 200-day MA of 31.07, indicating a bearish trend. The MACD of -0.55 indicates Positive momentum. The RSI at 31.88 is Neutral, neither overbought nor oversold. The STOCH value of 49.06 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for ABLG.
ABLG Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| ABLG | $28.31 | $30.00(5.96% Upside) | $13.06M | 0.54% | 61Neutral |
 GIEQ | $40.99 | $48.86(19.21% Upside) | $61.89M | 0.30% | 66Neutral |
 PJIO | $57.60 | $79.12(37.36% Upside) | $59.07M | 0.54% | 64Neutral |
 AADR | $80.02 | $95.79(19.71% Upside) | $35.14M | 1.09% | 69Neutral |
 VNIE | $24.46 | $28.73(17.47% Upside) | $8.65M | 0.60% | 63Neutral |
 PGRI | $25.52 | $31.16(22.11% Upside) | $6.47M | 0.55% | 70Outperform |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| ABLG | Abacus FCF International Leaders ETF | 28.31 | -1.83 | -6.06% | |
| GIEQ | Goldman Sachs Data Enhanced International Equity ETF | 40.98 | 0.49 | 1.21% | |
| PJIO | PGIM Jennison International Opportunities ETF | 57.60 | -4.99 | -7.97% | |
| AADR | AdvisorShares Dorsey Wright ADR ETF | 80.02 | -1.50 | -1.84% | |
| VNIE | Vontobel International Equity Active ETF | 24.45 | -0.26 | -1.03% | |
| PGRI | Putnam International Stock ETF | 25.52 | 0.67 | 2.70% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.